BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8644427)

  • 1. [Adjuvant systemic chemotherapy in colon cancer].
    Raskov HH
    Ugeskr Laeger; 1996 Feb; 158(9):1222-7. PubMed ID: 8644427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy of colorectal cancer.
    Kemeny N; Saltz L; Cohen A
    Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant postoperative therapy of gastrointestinal malignancies.
    Ilson DH; Kelsen DP
    Oncology (Williston Park); 1994 Jul; 8(7):75-83; discussion 83, 88-90, 95. PubMed ID: 7917843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adjuvant therapy in colorectal cancer.
    Hesketh PJ; Bulger KN
    Adv Intern Med; 1991; 36():219-47. PubMed ID: 2024581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
    Kodaira S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvant treatment for colon carcinoma. Results and perspectives].
    Wein A; Riedel C; Lehnert T; Wakker R; Reingruber B; Teichmann W; Kohnen R; Herfarth C; Hohenberger W; Hahn EG
    Dtsch Med Wochenschr; 1998 May; 123(21):674-80. PubMed ID: 9638096
    [No Abstract]   [Full Text] [Related]  

  • 10. The addition of low-dose leucovorin to the combination of 5-fluorouracil- levamisole does not improve survival in the adjuvant treatment of Dukes' C colon cancer. IKN Colon Trial Group.
    Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT
    Ann Oncol; 2000 May; 11(5):547-52. PubMed ID: 10907947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
    Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
    J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
    Kodaira S; Shatari T; Nozawa K
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant treatment of colonic carcinoma].
    Rochlitz CF; Herrmann R
    Praxis (Bern 1994); 1995 Nov; 84(47):1373-6. PubMed ID: 7501918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ
    J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients.
    Sargent DJ; Goldberg RM; Jacobson SD; Macdonald JS; Labianca R; Haller DG; Shepherd LE; Seitz JF; Francini G
    N Engl J Med; 2001 Oct; 345(15):1091-7. PubMed ID: 11596588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for colon cancer.
    Ducreux M; Boige V
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):283-98. PubMed ID: 11969239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
    Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
    J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
    Porschen R; Bermann A; Löffler T; Haack G; Rettig K; Anger Y; Strohmeyer G;
    J Clin Oncol; 2001 Mar; 19(6):1787-94. PubMed ID: 11251010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
    Chua YJ; Zalcberg JR
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal duration of fluorouracil plus levamisole colon cancer surgical adjuvant therapy.
    O'Connell MJ; Kahn MJ; Erlichman C; Goldberg RM; Shepherd LE
    J Clin Oncol; 1996 Oct; 14(10):2887. PubMed ID: 8874353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.